Claypoole Robert E bought BVS
January 9, 2026 · Form 4 insider transaction
Claypoole Robert E bought 93,750 shares of Bioventus Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
93,750
Price
$0.00
Total value
N/A
InsiderClaypoole Robert E
Role—
CompanyBioventus Inc. (BVS)
SecurityClass A Common Stock
Transaction codeM: Option exercise
Transaction dateJanuary 9, 2026
Filing dateJanuary 13, 2026
Shares owned after158,714
OwnershipDirect
10b5-1 planNo
AmendedNo